GET DAILY SIGNALSHIVE vs HUT: Contrasting Paths in the Shift to AI Data Centers
Key Takeaways
- Both HIVE and HUT started as Bitcoin miners and are now moving toward AI and high-performance computing infrastructure, though they are at different points in that transition.
- HIVE operates on a smaller scale with AI contracts already contributing to revenue, whereas HUT holds a substantially larger contracted backlog that remains mostly pre-revenue.
- HUT carries a notably higher valuation multiple relative to sales, while HIVE appears more modestly valued even with ongoing losses.
- Tickeron AI Verdict: Drawing on factors such as near-term revenue drivers, valuation, and positioning, the AI framework currently favors HIVE.
- Additional context is available through HIVE Major News and HIVE Today's Price Move, along with HUT Major News and HUT Today's Price Move.
- Curated algorithmic strategies for prevailing conditions can be reviewed on the Trending AI Robots page.
Setting the Stage for This Comparison
This analysis looks at two companies that began in Bitcoin mining and are now redirecting efforts toward AI infrastructure. HIVE, or HIVE Digital Technologies, runs green-energy data centers in Canada, Sweden, and Paraguay. HUT, or Hut 8 Corp, has shifted into an energy infrastructure platform after spinning off its Bitcoin mining operations and now centers on large-scale AI data centers. Investors tracking digital infrastructure, cryptocurrency ties, and the broader AI compute expansion may find value in comparing their approaches to the same trends.
HIVE Overview and Recent Performance
HIVE follows a dual strategy that combines Bitcoin mining with its AI/HPC segment, BUZZ HPC. The company has highlighted its AI progress through multi-year GPU cloud deals, including an approximately $220 million contract with Bell Canada and Cohere plus a five-year agreement worth roughly $350 million that should push BUZZ HPC's annualized recurring revenue run rate toward $180 million. It has also arranged about $129 million in fixed-rate financing to support further NVIDIA GB200 GPU deployments. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Even with these developments, the share price has stayed volatile and remains well below its 52-week high amid concerns over capital needs, dilution, a Swedish tax matter, and continued net losses despite rising revenue. Analyst views stay generally constructive, yet the market has not fully reflected the AI shift in the price.
HUT Overview and Recent Performance
HUT has repositioned more decisively as an AI and power infrastructure provider. After spinning off its Bitcoin mining into American Bitcoin Corp, the company has built a sizable pipeline of AI capacity, anchored by a 15-year lease agreement valued at roughly $9.8 billion with a major technology customer and an overall contracted AI backlog in the tens of billions of dollars. From what I see, recent weeks brought a sharp pullback in the stock alongside other AI infrastructure names, influenced by sector valuation worries and the gradual pace of revenue from contracts. Quarterly revenue has risen strongly year over year, but sizable net losses persist and the elevated price-to-sales ratio leaves little margin for execution issues. Longer-term performance has been positive, though near-term momentum has eased.
Head-to-Head Comparison
The companies differ most in scale and timing. HUT holds a multi-billion-dollar market capitalization and a far larger contracted backlog, yet much of that value depends on infrastructure that is contracted but not yet generating revenue, which adds execution and timing risk. HIVE is smaller with more limited revenue, but its AI contracts are moving toward recurring revenue on a faster timeline. Valuation metrics diverge as well: HUT trades at a price-to-sales multiple well above typical software and peer levels, while HIVE registers at a more moderate multiple. Both remain exposed to Bitcoin price movements and energy costs, and both post net losses amid heavy capital spending. Growth paths vary, with HIVE relying on nearer-term GPU cloud revenue and HUT depending on extended, large-scale data center leases. Common risks include financing costs, dilution, and the difficulty of turning announced contracts into actual cash flow.
Tickeron AI Verdict
Considering observable elements such as near-term revenue catalysts, valuation, and relative positioning, the AI framework currently shows a modest preference for HIVE. Its AI/HPC contracts appear closer to delivering recurring revenue, and the valuation multiple looks less stretched than that of HUT. HUT offers greater scale and a higher-profile backlog, but the richer valuation and slower revenue ramp add uncertainty. This view is probabilistic and should be weighed against individual research.
Integrating AI Tools Into My Research
When reviewing names like these, I often turn to Tickeron’s AI Trading Bots to test how different algorithmic strategies might perform across similar infrastructure stocks. The platform offers a range of bots with varying timeframes and risk settings, which helps me cross-check signals and explore alternative approaches without building everything from scratch. It has become a practical part of staying consistent in fast-moving sectors.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HIVE in downward trend: price dove below 50-day moving average on October 05, 2026
HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 34 of 37 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 69 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for HIVE entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for HIVE's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 64 cases where HIVE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for HIVE just turned positive on October 29, 2026. Looking at past instances where HIVE's MACD turned positive, the stock continued to rise in 30 of 38 cases over the following month. The odds of a continued upward trend are 79%.
Following a +11.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in 213 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.108). P/E Ratio (9.174) is within average values for comparable stocks, (6.904). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.800) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.899).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers
Advertisement